Consensus IMAX Corporation

Equities

IMAX

CA45245E1097

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
17.13 USD +0.12% Intraday chart for IMAX Corporation +4.26% +14.05%

Evolution of the average Target Price on IMAX Corporation

Price target over the last 5 years

History of analyst recommendation changes

079c3b7db8f28.TDTzM5Wn3CMuqnNKWsC7whXFQSSGrkEk-4xQPpC389U.JxmpY_HMuHND7zkkLJHJoV6IcWni3XlTy7Qof-TwioB-RLVDooqtakzwNg~4b94c900f7aee394a873c7d5e448d0ee
B. Riley Securities Raises Imax's PT to $25 From $21 After Q4 2023 Results Exceed Estimates, Keeps Buy Rating MT
Rosenblatt Adjusts Imax's Price Target to $25 From $30, Keeps Buy Rating MT
Benchmark Cuts Imax's Price Target to $22 From $24, Keeps Buy Rating MT
Goldman Sachs Adjusts Imax Price Target to $13 From $15, Maintains Sell Rating MT
B. Riley Lowers Imax's PT to $21 From $27, Notes Near-Term Domestic Industry Box Office Concerns; Maintains Buy Rating MT
Benchmark Adjusts Price Target on Imax to $24 From $23, Keeps Buy Rating MT
Rosenblatt Adjusts Price Target on Imax to $30 From $27, Maintains Buy Rating MT
Benchmark Adjusts Price Target on Imax to $23 From $22, Maintains Buy Rating MT
Roth MKM Adjusts Imax's Price Target to $26 From $24, Keeps Buy Rating MT
Wells Fargo Adjusts Price Target on Imax to $25 From $22, Maintains Overweight Rating MT
Rosenblatt Adjusts Price Target on Imax to $27 From $25, Maintains Buy Rating MT
B. Riley Lifts Imax's Price Target to $27 From $26 After Higher-Than-Expected Q1 Results, Keeps Buy Rating MT
Wedbush Lifts Imax's Price Target to $26 From $25 After 'Solid' Q1 Results, Keeps Outperform Rating MT
Wedbush Raises Imax's Price Target to $25 From $22, Notes 'Strong' Trends; Keeps Outperform Rating MT
Goldman Sachs Raises Price Target on Imax to $15 From $14, Maintains Sell Rating MT
B. Riley Raises Imax's Price Target to $26 From $23 on Improved Optimism on Box Office Outlook Into 2024, Keeps Buy Rating MT
Goldman Sachs Adjusts Price Target on Imax to $14 From $12, Maintains Sell Rating MT
Barrington Raises Imax's Price Target to $22 From $20, Maintains Outperform Rating MT
Bad surprise Our Logo
ANALYST RECOMMENDATIONS : Domino's Pizza, Imax, Moderna, W.W. Grainger... Our Logo
Benchmark Raises Imax's Price Target to $22 From $18, Maintains Buy Rating MT
Roth MKM Raises Imax's Price Target to $24 From $21, Maintains Buy Rating MT
Morningstar Downgrades Imax to Hold From Buy, $19 Price Target MT
JPMorgan Raises Imax's Price Target to $19 From $16, Maintains Neutral Rating MT
Rosenblatt Securities Adjusts Imax's Price Target to $25 From $22, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.13 USD
Average target price
21.65 USD
Spread / Average Target
+26.39%
High Price Target
25 USD
Spread / Highest target
+45.94%
Low Price Target
14.5 USD
Spread / Lowest Target
-15.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering IMAX Corporation

B. Riley
Rosenblatt Securities
Benchmark Company
Goldman Sachs
Roth MKM
Wells Fargo Securities
Wedbush
Barrington Research
JPMorgan Chase
Morningstar
Truist Securities
Benchmark Capital
Macquarie
MKM Partners
Colliers Securities
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock Market
  2. Equities
  3. IMAX Stock
  4. Consensus IMAX Corporation